in

Prenatal exposure to phentermine-topiramate lower under safety program

Prenatal exposure to phentermine-topiramate lower under safety program

Under the Risk Evaluation and Mitigation Strategy (REMS), prenatal exposure to phentermine-topiramate is lower than topiramate and other antiobesity medications (AOMs), according to a study published online March 21 in the Annals of Internal Medicine.


Posted by Editor

Saul Nash Really Wants to Move Equinox Members With New Collaboration

Saul Nash Really Wants to Move Equinox Members With New Collaboration

Google Chrome Now Shows Shortcuts to Previous Search Queries on the New Tab Page: Details

Chrome Now Shows Shortcuts to Your Previous Searches on the New Tab Page